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REVIEWS
What aspects of body fat are particularly
hazardous and how do we measure them?
MB Snijder,1,2* RM van Dam,1,3 M Visser1,2 and JC Seidell1,2
Introduction
There is a worldwide increase in the prevalence of obesity,
1
which contributes to a higher incidence of cardiovascular disease
and type 2 diabetes mellitus.
2,3
It has been projected that by
2020, type 2 diabetes and cardiovascular disease will account for
almost three-fourth of all deaths worldwide.
4
Since the 1950s it has been recognized that apart from overall
obesity the distribution of body fat can influence disease risk.
5
In particular an abdominal fat distribution is associated with
metabolic disturbances and increased risk of cardiovascular
disease and type 2 diabetes. In the present paper we will discuss
different ways to measure body composition and focus on which
aspects of body fatness (e.g. central vs total, subcutaneous vs
visceral) are particularly hazardous in terms of morbidity and
mortality.
How to measure body fat?
Body fat measurements
Numerous techniques are available to estimate body composition
and fat distribution, and the method to use will depend on the
aim of the study, economic resources, availability, time, and
sample size.
6–8
Multi-compartment models, such as underwater
weighing, dilution techniques and dual-energy X-ray absorp-
tiometry (DXA) are all reliable methods to obtain accurate
measures of total body fat. However, because of their costs in
terms of time andmoney, thesemethods are not practical in large
epidemiological studies and for routine clinical use. In these
situations, body mass index (BMI) is often used and assumed to
represent the degree of body fat. BMI, however, does not dis-
tinguish between fat mass and lean (non-fat) mass. For example,
well-trained body builders have a very low percentage of body
fat, but their BMI may be in the overweight range because of
their large lean (muscle) mass. In addition, in the elderly and
non-Caucasian populations, the relationship between BMI and
body fatness may be different as compared with younger
Caucasian populations.
9–14
Another potential limitation of the BMI is that the distribution
of fat over the body is not captured. Many studies have shown
that an abdominal fat distribution, independent of overall
obesity, is associated with metabolic disturbances and increased
disease risk.
15–23
An increased abdominal fat accumulation is
largely caused by the accumulation of visceral (or intra-
abdominal) fat (for distinction of these fat depots, see Figure 1).
Owing tometabolic differences between different fat depots, they
differ in their role of predicting metabolic disturbances and
diseases. Table 1 summarizes the capability of the most
commonly used methods to assess total adiposity and fat dis-
tribution. Abdominal obesity is usually assessed by the easily
measured waist circumference, the waist-to-hip circumference
ratio (WHR), or the less-commonly used sagittal abdominal
diameter (SAD). By the use of sophisticated imaging techniques,
such as magnetic resonance imaging (MRI) and computed
tomography (CT), different fat depots can be distinguished at the
waist level, and it has been shown that in particular the visceral
fat depot is associated with metabolic disease risk.
24–30
Because
the SAD or waist circumference alone are more strongly cor-
related with visceral fat than the WHR,
31–35
guidelines tend to
focus onwaist circumference to estimate disease risk as suggested
by Lean et al.
36
These widely used cut-points (i.e. 102 cm formen
and 88 cm for women) were originally based on a replacement of
the classification of BMI,
36
but other cut-points have also been
suggested on the basis of relationships with visceral fat area.
37
Subcutaneous fat
Visceral fat
Figure 1 Cross-section of the abdomen in which subcutaneous and
visceral fat can be distinguished. Lighter-coloured areas are muscles,
bones, and organs
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These simple cut-points may be helpful for the classification of
Caucasian adults, but they are probably less appropriate in other
ethnic groups
38
or older age groups.
39
No large or consistent
differences have been found between SAD and waist circum-
ference in relation to visceral fat.
31,33–35,40,41
The waist circumference, however, is not always a stronger
predictor of type 2 diabetes
42,43
and other cardiovascular
risk
16,20,44–46
than the WHR. Because a higher WHR can be
the result of a larger waist as well as a smaller hip, this suggests
that a smaller hip (representing either lower muscle and/or fat
mass at the hips) may be involved in determining the increased
risk associated with an increased WHR. Hip circumference is
more strongly associated with leg fat mass, but also with leg lean
mass (particularly in men).
47
Indeed, WHR has been related to
both a larger trunk fat mass, and a smaller leg fat mass (both
sexes) and leg lean mass (men).
47
In another study, WHR has
been related to both larger visceral fat and smaller leg muscle
areas in men.
48
Several studies have found that a smaller hip
circumference (for a given waist circumference) is associated
with an increased risk.
43,49–56
Early studies on fat distribution often used skinfold measure-
ments to characterize subcutaneous fat distribution.
57
Subcuta-
neous fat patterns were described using Z-score patterns, ratios of
skinfolds (e.g. triceps/subscapular skinfold ratio and ratio of the
sumof trunk skinfolds to the sum of skinfolds on extremities) and
principal components analyses. The most promising and simple
indicator of central fat distribution using skinfolds seems to be
the subscapular skinfold. A prospective study showed that the
subscapular skinfold predicted coronary heart disease in men
independently of BMI and other cardiovascular risk factors
58
but
studies that have compared the use of skinfold over and above
the use of body circumferences or circumference ratios are rare.
A few studies have compared the associations between skinfolds
and circumferences in relation to components of the metabolic
syndrome
59,60
and these showed that correlations of waist
circumference with risk factors were either similar or stronger
comparedwith those of the subscapular skinfold.Misra et al. have
proposed that the subscapular skinfold should be considered
as an indicator of central fat distribution separately of the waist
circumference.
61
It is, however, difficult to say with certainty
that the measurements of skinfolds improve substantially the
prediction of disease independently of body circumferences.
Anthropometry in specific groups: older persons
The composition of the body changeswith age, and thismay have
serious implications for the interpretation of anthropometric data
of older persons. First, older persons are generally shorter than
younger persons owing to secular trends in height and owing to
shrinkage of the spine because of vertebral bone loss, kyphosis,
and scoliosis.
62,63
Consequently, the BMI of older persons
may be overestimated and it is, therefore, preferable to use a
body height measured in early life to calculate the BMI of older
persons. Second, with age the amount of lean body mass
decreases, a process called sarcopenia.
64
Sarcopenia occurs even
in weight stable persons owing to a concomitant increase in the
amount of body fat.
65,66
The relationship between BMI and
percentage of body fatness has been shown to be dependent on
age.
9
Data from the Rosetta Study show that older adults have,
on average, more fat than younger adults at any given BMI.
67
Prediction equations to estimate body composition fromBMIwill
generally underestimate the amount of body fat in the elderly.
68
Also, a similar skinfold thickness in young and older persons
represents a higher percentage of body fatness in older persons.
68
Age-specific prediction equations should be used to estimate
body fatness from skinfold thickness.
69
A recent study in older
men and women (mean age 60.4 years) showed that the change
in skinfold thickness over time did not predict change in body fat
mass, suggesting its limited use in longitudinal studies.
70
Finally,
the distribution of body fat also changes with age because
relativelymore fat accumulates in the abdomen and less fat at the
extremities.
71,72
Waist circumference has been suggested as an
indicator of overall body fatness in older persons.
73
Changes in
waist and hip circumference were better anthropometric pre-
dictors of change in body fat mass over a 10 year period compared
with changes in skinfold thickness.
70
However, in persons
aged 70–79 years the explained variance in total body fat
remained higher for BMI than for waist circumference.
74
The waist circumference has been shown to be similarly
correlated with the amount of visceral fat in young and older
persons.
75
In several studies, waist circumference was a better
predictor of visceral fat in older persons compared with SAD or
WHR.
32,76
However, in very old men and women (.70 years)
SADwas a better predictor of visceral fat comparedwith thewaist
circumference.
74
In that study the BMI performed as good as
the waist circumference in predicting visceral fat.
74
An
alternative, non-anthropometric method proposed to estimate
the amount of visceral fat in older persons is subregional DXA.
40
The prediction of visceral fat by DXA was better compared with
the waist circumference but was similar to the SAD.
For a givenwaist circumference, visceral fat has been shown to
be higher in older persons compared with younger persons,
76
suggesting that absolute levels of waist circumference should be
interpreted differently in younger and older persons. Prediction
equations for visceral fat generally include age.
77
Whether the
proposed waist circumference cut-points are useful for the
prediction of cardiovascular disease risk factors in older persons is
still unclear.
78,79
Table 1 Capability of different body fat measurements to estimate
total body fat and fat distribution
Method
Capability
measuring
total body fat
Capability
measuring fat
distribution
Applicability
in large
population
studies
CT Moderate Very high Low
MRI High Very high Low
DXA Very high High Moderate
Densitometry Very high Very low Low
Dilution techniques High Very low Moderate
BIA Moderate Very low High
Anthropometry
BMI Moderate Very low Very high
WC, HC, WHR, SAD Low High Very high
Skinfolds Moderate Moderate High
CT, computed tomography; MRI, magnetic resonance imaging; DXA, dual-
energy X-ray absorptiometry; BIA, bioelectrical impedance analysis; BMI, body
mass index; WC, waist circumference; HC, hip circumference; WHR, waist-to-
hip ratio; SAD, sagittal abdominal diameter.
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Anthropometry in specific groups: ethnicity
Several studies have shown a race difference in the association
between BMI and percentage of body fat. For a given BMI,
Chinese, Malay, Indian, Taiwanese, and Indonesian men and
women have a higher percentage of body fat compared with
Caucasians.
10–14
Differences in trunk-to-leg-length ratio,
slenderness, and muscularity may contribute to these racial
differences in the percentage of body fat–BMI relationship.
80,81
No clear differences in the relation between percentage of body
fat and BMI have been observed for African-Americans vs
Caucasians.
67
Based on these findings and the observed dif-
ferences in the relation between BMI and disease risk, lower BMI
cut-points have been suggested to define overweight and
obesity for specific ethnic groups.
10–12,82–84
However, the
expert committee of the WHO has not redefined the cut-
points for specific Asian populations, because available data do
not necessarily indicate a clear BMI cut-off point for all Asian
ethnic groups.
85
Ethnic differences in the relation between waist circumference
and visceral fat have frequently been reported. Asian ethnic
groups generally have a smaller waist circumference compared
with Caucasians, although this is not necessarily true for Asian
emigrants who are generally affluent and have more generalized
and abdominal obesity.
38,86
Despite the smaller waist circum-
ference, the visceral fat mass is higher for Asians compared with
Caucasians and African-Americans.
87,88
Moreover, for specific
Asian groups disease risks may already be increased at a lower
level of waist circumference, suggesting that a lowering of the
waist circumference cut-points should be considered for these
ethnic groups.
38,82,83
For a similar waist circumference (or
WHR) and BMI, African-Americans have a lower visceral fat
mass compared with Caucasians.
89–91
Although a larger amount
of visceral fat is associated with a higher disease risk in both
African-Americans and Caucasians, similar amounts of visceral
fat are associated with different levels of metabolic risk factors in
these groups.
92
The cause of the more diabetogenic profile in
African-Americans as compared with Caucasians is currently
unknown.
93
Epidemiology of body fat measures and
associated disease risk
Time trends and prevalence of abdominal obesity
Secular changes in the prevalence of overweight and obesity as
measured by BMI have been reported in many countries over
the last decades.
1
Several studies have reported on secular
changes in waist circumference andWHR. In German adults and
in British adolescents, stronger increases over time in the average
waist circumference than in relative weight were observed.
94,95
A more rapid secular increase in WHR than in BMI was shown
in Swedish women.
96
Lahti-Koski et al.
97
observed a similar
secular change but did not compare this to the time trend in BMI.
Amore recent study from Sweden observed a significant increase
in BMI but not in WHR in the period from 1985 to 2002.
98
A
Dutch study showed similar secular changes in waist circum-
ference as compared with BMI over a short period of time.
99
Large increases in the waist circumference were shown in the
US adult population from 1960 to 2000 in all categories of
BMI.
100
It has been suggested that the waist circumference is
more sensitive to changes in energy balance (e.g. decreased
physical activity) than the BMI.
99
With decreasing physical
activity muscle may be gradually replaced by fat mass and this
may have less effect on overall body weight than on the waist
circumference.
The prevalence of abdominal obesity according to these
cut-points has been reported for several countries. In the US the
age-adjusted prevalence of abdominal adiposity has tripled in
men from ~13% in 1960–62 to 38% in 1999–2000. In women
the prevalence increased from ~19 to 60% over the same
period.
100
In The Netherlands the prevalence of abdominal
obesity was ~15% in men and 21% in women in 1993–97.
99
These prevalences were similar to those of the US some 30 years
earlier.
Body fat measures in relation to cardiovascular
disease and type 2 diabetes
The worldwide increase in the prevalence of (abdominal) obesity
is alarming because of the associated disease risk, in particular
type 2 diabetes and cardiovascular diseases. Several studies were
conducted to compare the contribution of measures of overall
obesity (BMI) and abdominal obesity (waist circumference,
WHR, SAD) with disease risk. Overall, it can be concluded that
persons with a BMI in the normal weight range can still be at
increased risk of metabolic disturbances if the WHR or waist
circumference is increased, and that the combination of a high
BMI and a high WHR results in a particularly high risk of an
unfavourable metabolic profile, type 2 diabetes, and cardiovas-
cular diseases.
15–23
In the elderly, few studies have directly compared BMI and
waist circumference as predictors ofmetabolic abnormalities. The
limited available data suggest that waist circumference and/or
SAD are better indicators of cardiovascular risk factors in older
men and women compared with BMI.
21,101
However, in other
studies waist circumference contributed little to the prediction of
disease risk after BMI had been taken into account.
102,103
Regarding the comparison of waist circumference andWHR as
predictors of metabolic disturbances and the risk of cardiovas-
cular diseases, results have been inconsistent. Some studies have
found waist circumference a stronger correlate of metabolic risk
factors and cardiovascular disease than the WHR,
31,104,105
whereas others found no difference,
106–108
or found that the
WHR was superior.
16,20,42–46
The last observation resulted in
several studies that investigated the separate contributions of
waist and hip circumferences to disease risk. These studies
consistently show that a smaller hip circumference, for a given
waist circumference, is related to an increased risk for metabolic
disturbances,
49–51,53
type 2 diabetes,
43,50,52,54
and cardiovas-
cular disease and mortality.
52,55,56
These results suggest that the
measurement of hip circumference can contribute to the
prediction of cardiovascular disease risk.
If waist circumference orWHRwere comparedwith the SAD in
the prediction of metabolic disturbances and disease risk, some
studies found SAD a stronger correlate than waist circumference,
WHR, and BMI.
109–111
However, waist and SAD correlated
similarly (but stronger than WHR) with metabolic variables in
another study.
31
In others, none of these three measures was
superior in their association with metabolic disturbances or
cardiovascular disease risk.
106
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Considering more sophisticated body composition measure-
ments, numerous studies have shown a consistent and strong
association of CT-measured visceral fat area in relation to
metabolic or disease risk.
24–30
Results from the literature are not
consistent on whether abdominal subcutaneous fat area con-
tributes to an unfavourable metabolic profile and cardiovascular
disease, independently of visceral fat area.
112
In the Health,
Aging and body composition Study, a larger amount of
abdominal subcutaneous fat was substantially and independ-
ently associated with higher glucose and lipid levels, although
associations were stronger for visceral fat.
30
This independent
association of subcutaneous abdominal fat with metabolic risk
factors agrees with findings in earlier smaller studies.
113,114
Studies using DXA or CT to estimate fat and muscle content at
the legs found that in particular more subcutaneous fat at the
legs, and to a lesser extent muscle mass at the legs, was associated
with a more favourable cardiovascular risk profile (for a given
amount of abdominal fat).
30,47,115,116
Thus, the association of a
smaller hip circumference (for a given waist circumference) with
increased disease risk can mostly be explained by larger
peripheral fat mass.
Body fat distribution and premature mortality
Results for measures of body fatness and risk of premature
mortality are more difficult to interpret than results for disease
risk. First, causes of mortality can vary substantially for different
populations and the effects of body fatness on these underlying
causes will be different. Second, the induction time for effects of
body fatness on mortality is likely to be longer than for effects
on the development of diseases.
117
Third, associations between
anthropometry and mortality seem particularly prone to bias
owing to ‘reverse causation’: (subclinical) diseases that are
related to increased mortality can result in weight loss.
117,118
Fourth, most studies of adiposity and mortality have used BMI as
a measure of body fatness. Because BMI can reflect both fat and
lean body mass, variation in lean body mass that may be
associated with mortality can complicate the interpretation of
results for BMI. Indeed, the U-shaped association between BMI
and mortality that has been observed in some studies may reflect
the opposite monotonous relations of lean mass (beneficial)
and fat mass (detrimental) with risk of premature mortal-
ity.
119,120
Overall, study findings have indicated that obesity
(i.e. BMI > 30 kg/m2) increases the risk of premature
death.
118,121
However, results for lower levels of BMI in relation
to mortality have been less consistent, and methodological
limitations of studies have undoubtedly contributed to variation
in results.
118
Studies of body fat distribution and premature mortality have
been limited to studies of anthropometric measures of body fat
distribution. In several studies, larger waist circumference,
122
larger WHR,
16,44,123
larger iliac-to-thigh circumference,
124
larger SAD,
125
and smaller hip circumference
52,55,126
were
substantially associated with risk of premature mortality after
adjustment for BMI. Because BMI may also reflect variation in
lean body mass, one could argue that these independent asso-
ciations are owing to incomplete adjustment for overall body
fatness. However, measures of central fat distribution also
remained associated with premature mortality after adjustment
for overall body fatness assessed by skinfold thickness
44,127
or
bioelectrical impedance.
128,129
These results are consistent with
results for morbidity that suggest that given a certain degree of
body fatness, it is preferable to have fat stored in the femoral-
gluteal region instead of the abdominal region. It should be noted
that studies of body fat distribution and mortality have mostly
been conducted in white populations. Large waist circumference
was a stronger predictor of premature mortality than BMI in
black men,
130
but neither measure was clearly associated with
mortality in black women
131
possibly owing to the limited size of
the study.
Pathophysiology
The role of free fatty acids
Although the concept that obesity, in particular abdominal
obesity, is an important cause of metabolic disturbances is
generally accepted, the exact pathophysiological mechanisms
are not completely known. It is widely acknowledged that fatty
acids play an important role in the development of type 2
diabetes.
132–134
When free fatty acid levels in the circulation are
high (as in abdominal obesity
135
), glucose uptake and oxidation
by muscle and other organs is inhibited through several
mechanisms. The pancreas will compensate the diminished
glucose uptake by increasing insulin secretion, but inmany of the
insulin resistant persons, the beta-cell eventually fails. In
addition, free fatty acids will accumulate in organs (so-called
‘lipotoxicity’ or ‘ectopic fat storage’), particularly in the muscle
and in the liver, but also in the pancreas. Accumulation of fat in
non-adipose tissue may further promote insulin resistance and
impair beta-cell function, which are the two key features in the
development of type 2 diabetes.
133,136
Metabolic effects of different fat stores
Visceral fat is more sensitive to lipolytic stimuli, and less sensitive
to anti-lipolytic stimuli (such as insulin), compared with
subcutaneous fat. Therefore, visceral fat is more likely to release
free fatty acids into the circulation causing increased free fatty
acid levels, which may lead to ectopic fat storage in muscle, liver,
and pancreas.
133,137–139
It has been argued, however, that the
quantitative contribution to circulating free fatty acid levels of
subcutaneous fat is probably much larger because there simply is
much more of it.
112,140
However, the release of free fatty acids
from visceral fat into the portal vein that directly leads to the
liver, may cause reduced hepatic insulin clearance, increased
gluconeogenesis and increased dyslipidaemia.
141,142
Removal
of visceral fat reversed hepatic insulin resistance and prevented
age-induced insulin resistance and glucose intolerance in
rats,
143,144
whereas removal of equivalent amounts of subcu-
taneous fat had little effect.
144
And a pilot study in humans
suggests that omentectomy (removal of part of visceral fat) might
improve the metabolic profile.
145
From epidemiological studies (see above) it is unclear whether
a larger abdominal subcutaneous fat mass also contributes to an
increased disease risk, independently of visceral fat. In a study in
six obese women, surgical removal of abdominal subcutaneous
fat (55–65% of subcutaneous abdominal fat corresponding to
4.3 6 1.1 litres) by liposuction, led to improvement of
insulin sensitivity and glucose levels after 3–4 weeks.
146
Long-term consequences of subcutaneous liposuction are
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inconsistent, however.
147–149
Abdominal subcutaneous fat can
be further divided into deep and superficial subcutaneous
adipose tissue. It was demonstrated that the amount of deep
subcutaneous adipose tissue had a much stronger association
with insulin resistance than superficial subcutaneous fat, which
may be due to differences in lipolysis.
150,151
This difference
between different types of subcutaneous fat may have con-
tributed to the inconsistent results regarding removal of
total abdominal subcutaneous fat and changes in insulin
resistance.
As also described in a previous section, recent studies suggest
that more peripheral subcutaneous fat in the legs, for a given
amount of abdominal fat, may be associated with a more
favourable cardiovascular risk profile.
47,115,116
It has been
suggested that the femoral-gluteal fat depot plays a protective
role by acting as a ‘sink’ for circulating FFA.
152
Adipocytes in the
femoral region are relatively insensitive to lipolytic stimuli and
have a high sensitivity for anti-lipolytic stimuli. The enzyme
lipoprotein lipase (LPL) plays an important role in the uptake of
free fatty acids from the circulation, and particularly in women,
the femoral fat depot has a relatively high LPL activity and
relatively low rate of basal and stimulated lipolysis.
153,154
Therefore, the femoral-gluteal region is more likely to effectively
take up FFA from the circulation and is less likely to release them
readily. As a result of FFA uptake in the femoral-gluteal region,
detrimental ectopic fat storage in the liver, skeletal muscle, and
pancreas, may be prevented.
136
In line with this potential mechanism, transplantation of
subcutaneous adipose tissue in lipoatrophic animals reversed
elevated glucose levels
155
and subcutaneous lipectomy caused
metabolic disturbances in hamsters.
156
In humans, the critical
role of subcutaneous adipose tissue is illustrated by the observa-
tion that adipose tissue deficiency (lipodystrophy or lipoatrophy)
is accompanied by ectopic fat storage, insulin resistance, and type
2 diabetes.
136
No studies have been conducted that compared
the effects of liposuction in the femoral-gluteal region with
liposuction in the abdominal region. The medical drugs thiazo-
lidinediones increases insulin sensitivity in insulin resistant
patients, while a considerable amount of total body fat is
accumulated. These drugs promote preadipocyte differentia-
tion intomature adipocytes, in particular in the gluteal regions.
157
These new mature adipocytes have a better capacity to store
lipids, which may result in reduced ectopic fat deposition,
and consequently in improved insulin resistance and beta-cell
function.
Alternative or additional explanations for the
associations of fat depots and disease risk
Adipose tissue secretes many signalling proteins and cytokines
with broad biological activity and critical functions. Some of
these adipokines may be involved in the development of insulin
resistance in obesity.
158
The secretory functions of adipose tissue
is probably also subject to regional variations.
159
Therefore, the
different associations of abdominal and femoral-gluteal subcu-
taneous fat depots with metabolic risk factors may be due to
differences in the secretion of adipokines between the fat
depots. There are known differences in endocrine secretion of
leptin, adiponectin, and IL-6 between abdominal subcutaneous
fat and visceral fat,
160–162
whereas the existence of regional
differences in the secretion of plasminogen activator inhibitor-1
(PAI-1) and TNF-alpha is controversial.
159
Little is known about
possible differences in the secretion of these adipokines
between abdominal and femoral-gluteal subcutaneous fat. In
addition, there are probably many more yet undiscovered
proteins, differently secreted by different fat depots, whichmight
influence metabolic function. Clearly, more research in this area
is needed.
There are several factors that may influence body fat pattern-
ing aswell as thedevelopmentofmetabolic disturbances andmay,
therefore, underlie or confound the associations between these
phenomena. These factors include behavioural factors (smoking,
physical activity, diet), hormonal factors (disturbances in gluco-
corticoid metabolism, sex hormones, growth hormone), and
demographic factors such as age and gender.
163,164
Recently, it
has been shown that fat depots are also innervated by the
parasympathetic nervous system, in addition to the earlier finding
of a sympathetic innervation, and that stimulation of the
parasympathetic nervous system promotes lipid accumula-
tion (anabolic function).
165
Kreier et al.
166
have proposed an
unbalanced and disturbed autonomic nervous system function as
a major cause of changed body fat storage and the metabolic
syndrome.
Conclusions
In conclusion, it is supported by mechanistic studies, studies of
metabolic risk factors, and studies of cardiovascular disease and
premature mortality, that body fat distribution is relevant for the
risk of cardiovascular disease and mortality. Time trend studies
have shown that there is a consistent increase over time in the
prevalence of obesity and, particularly, abdominal obesity, which
is likely to contribute to a higher incidence of type 2 diabetes,
cardiovascular disease, and mortality.
Severalmethods are available tomeasure body fatness, and the
choice largely depends on the purpose. For clinical applications it
should be considered that usually no information on body fatness
is collected at all and the health problems of being overweight are
often not discussed by clinicians with their patients.
167
The
systematic, repeated collection of a measure of body fatness in
clinical practice may already be an important step forward and
the simplicity of the measurement is an important consideration.
For this purpose, BMI can be an adequate measure of body
fatness in adults. However, waist circumference may be a simple
alternative that also captures information on abdominal fat
distribution and may be less affected by variation in lean mass.
The WHR is more difficult to interpret because it may reflect an
effect of larger waist as well as a smaller hip circumference. The
SAD can be used instead of waist circumference but has not
consistently been shown to be superior for the prediction of
disease risk.
For large epidemiological studies the BMI can capture most
of the relevant variation in body fatness depending on the age of
the study population. However, many studies have shown that
the collection of information on body fat distribution (waist
circumference,WHR, SAD, DXA) can provide additional insights.
For mechanistic studies and intervention studies with exposures
that may affect body fat distribution, accurate methodology to
assess fat depots (CT, MRI, DXA) is necessary.
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